Ser150
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser150  -  CASP3 (human)

Site Information
FRGDRCRsLtGKPKL   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 450984

In vivo Characterization
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling ( 2 ) , immunoprecipitation ( 2 ) , mutation of modification site ( 2 ) , phosphopeptide mapping ( 2 )
Relevant cell line - cell type - tissue:
neutrophil ( 2 )

Upstream Regulation
Putative in vivo kinases:
P38A (human) ( 2 )
Kinases, in vitro:
P38A (human) ( 2 )

Downstream Regulation
Effects of modification on CASP3:
activity, inhibited ( 2 )
Effects of modification on biological processes:
apoptosis, inhibited ( 2 )

References 

1

Thomas ME, Grinshpon R, Swartz P, Clark AC (2018) Modifications to a common phosphorylation network provide individualized control in caspases. J Biol Chem
29414778   Curated Info

2

Alvarado-Kristensson M, et al. (2004) p38-MAPK signals survival by phosphorylation of caspase-8 and caspase-3 in human neutrophils. J Exp Med 199, 449-58
14970175   Curated Info